Marta Ragonese

Dr. Marta Ragonese


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2014 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
SCSalvatore Cannavo'
Salvatore Cannavo'
FFFrancesco Ferrau'
Francesco Ferrau'
MRMarta Ragonese
Marta Ragonese
PRP. D. Romeo
P. D. Romeo
MTM. L. Torre
M. L. Torre
FTF. Trimarchi
F. Trimarchi

27 November 2013 in Endocrine
Verified
Journal Article
Closed access
PDF file
MRMarta Ragonese
Marta Ragonese
AAAngela Alibrandi
Angela Alibrandi
GBGianluca Di Bella
Gianluca Di Bella
ISIgnazio Salamone
Ignazio Salamone
Soraya PuglisiSoraya Puglisi
Soraya Puglisi
SCSalvatore Cannavo'
Salvatore Cannavo'

AGAnnalisa Giandalia
Annalisa Giandalia
MRMarta Ragonese
Marta Ragonese
EAEugenio Alessi
Eugenio Alessi
MRMaria C. Ruffo
Maria C. Ruffo
Alberto SardellaAlberto Sardella
Alberto Sardella
Giuseppina Tiziana RussoGiuseppina Tiziana Russo
Giuseppina Tiziana Russo
Background: The Locus of Control (LOC) is a mental disposition indicating the individuals’ belief that disease-related outcomes are under their own control (Internal), dependent on others (External), or dependent on chance (Chance). Quality of Life (QoL) and LOC may have complex effects on self-care activities and diabetes management in subjects with type 2 diabetes (T2D). The aim of the present study was to evaluate the predictive role of LOC and QoL scores on metabolic control in elderly T2D outpatients, secondly evaluating potential gender differences. Methods: An extensive set of questionnaires was administered to a group of consecutive elderly T2D outpatients on oral glucose-lowering drugs attending a single diabetes center. Personal and clinical variables were analyzed at baseline (between 1 February and 31 March 2015) and after 6 years of follow-up. Results: At baseline, study participants showed an overall good metabolic control. Diabetes Specific Quality of Life (DSQoL) scores indicated an overall good QoL in both genders, with a higher DSQoL satisfaction score in women. Both genders presented higher scores in the LOC-Internal domain, with men reaching higher scores in the LOC-External domain than women. At the 6-years follow-up, subjects with baseline higher LOC-External score presented better metabolic outcome. In the regression analysis, LOC-External score was an independent predictor of good metabolic control maintenance, but this result was only statistically significant in men. Conclusions: LOC scores may influence long-term glycemic control in elderly T2D patients on oral glucose-lowering drugs.

23 December 2021 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Open access
PDF file
MRMarta Ragonese
Marta Ragonese
GBGianluca Di Bella
Gianluca Di Bella
FSFederica Spagnolo
Federica Spagnolo
LGLoredana Grasso
Loredana Grasso
AAAngela Alibrandi
Angela Alibrandi
SCSalvatore Cannavò
Salvatore Cannavò
Background Acromegaly is associated with an increased risk of fatal and non-fatal cardiovascular (CV) events. Controlling acromegaly decreases, but does not normalize this risk. Brain natriuretic peptide (BNP) assessment is used in the general population for the diagnosis of heart failure and to predict ischemic recurrences and mortality. This is a retrospective, longitudinal, monocenter study that evaluates the role of serum N-terminal fragment of BNP (NT-pro-BNP) for predicting CV events in acromegaly patients. Methods Serum NT-pro-BNP levels were measured in 76 patients with acromegaly (23 males, 57.7±1.5 years), and compared with other predictors of CV events. NT-pro-BNP cut-off value discriminating the occurrence of CV events was determined by ROC analysis. CV events were recorded during a follow-up of 78.6±6.4 months. Results CV events occurred in 9.2% of patients. Mean log(NT-pro-BNP) concentration was higher in patients who experienced CV events than in those who did not (p<0.01) and in patients who died due to CV events than in those who died due to other causes (p<0.01). Based on the ROC curve, a cut-off value of 91.55 pg/mL could predict CV events (OR 19.06). Log(NT-pro-BNP) was lower in surgically treated patients by surgery (p<0.05), and in those cured by neurosurgery (p<0.02). Conclusions High NT-pro-BNP value is an independent middle-term predictor of fatal or non-fatal CV events in patients with acromegaly. According to this parameter, surgically treated patients show lower CV risk than those managed with medical therapy, especially if the disease is cured.